[go: up one dir, main page]

AU2001286519A1 - Method for identifying modulators of "mec"-induced functions of ccr3 and/or ccr10 - Google Patents

Method for identifying modulators of "mec"-induced functions of ccr3 and/or ccr10

Info

Publication number
AU2001286519A1
AU2001286519A1 AU2001286519A AU8651901A AU2001286519A1 AU 2001286519 A1 AU2001286519 A1 AU 2001286519A1 AU 2001286519 A AU2001286519 A AU 2001286519A AU 8651901 A AU8651901 A AU 8651901A AU 2001286519 A1 AU2001286519 A1 AU 2001286519A1
Authority
AU
Australia
Prior art keywords
ccr10
ccr3
mec
identifying modulators
induced functions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286519A
Inventor
Eugene C Butcher
Eric J. Kunkel
Junliang Pan
Dulce Soler-Ferran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Leland Stanford Junior University
Original Assignee
Millennium Pharmaceuticals Inc
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc, Leland Stanford Junior University filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001286519A1 publication Critical patent/AU2001286519A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001286519A 2000-08-15 2001-08-15 Method for identifying modulators of "mec"-induced functions of ccr3 and/or ccr10 Abandoned AU2001286519A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63891400A 2000-08-15 2000-08-15
US09638914 2000-08-15
PCT/US2001/025734 WO2002014532A2 (en) 2000-08-15 2001-08-15 Method for identifying modulators of 'mec'-induced functions of ccr3 and/or ccr10

Publications (1)

Publication Number Publication Date
AU2001286519A1 true AU2001286519A1 (en) 2002-02-25

Family

ID=24561972

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286519A Abandoned AU2001286519A1 (en) 2000-08-15 2001-08-15 Method for identifying modulators of "mec"-induced functions of ccr3 and/or ccr10

Country Status (3)

Country Link
US (1) US6692922B2 (en)
AU (1) AU2001286519A1 (en)
WO (1) WO2002014532A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531069A (en) * 2001-08-10 2007-01-26 Topigen Pharma Inc Methods for modulating viral infection of cells by modulating a binding interaction between a CCR1, CCR2, CCR3, CCR4, CCR5 and/or CCR8 receptor and a surface protein of the virus
EP1367396A1 (en) * 2002-05-29 2003-12-03 Bayer Aktiengesellschaft Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (CCR10)
WO2005108989A2 (en) * 2004-04-16 2005-11-17 Genentech, Inc. Assay for antibodies
WO2005106492A2 (en) * 2004-04-30 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3)
US8008092B2 (en) * 2007-10-09 2011-08-30 University Of Kentucky Research Foundation CCR3 inhibition for ocular angiogenesis and macular degeneration
US10053695B2 (en) * 2014-03-26 2018-08-21 The Penn State Research Foundation Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
CN109022599A (en) * 2018-10-08 2018-12-18 河南科技学院 The kit and RFLP method and related SNP s of detection milk cow CCL28 gene mononucleotide polymorphism
CN113985035A (en) * 2021-10-28 2022-01-28 重庆市中医院 Application of chemokine CCL28 as marker in preparation of Sjogren syndrome diagnostic reagent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539507A (en) * 1983-03-25 1985-09-03 Eastman Kodak Company Organic electroluminescent devices having improved power conversion efficiencies
US5059861A (en) * 1990-07-26 1991-10-22 Eastman Kodak Company Organic electroluminescent device with stabilizing cathode capping layer
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
US6512103B1 (en) 1995-12-08 2003-01-28 Schering Corporation Mammalian chemokine reagents
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
EP0944723B1 (en) 1996-11-27 2004-04-28 Schering Corporation Mammalian chemokines
US5739545A (en) * 1997-02-04 1998-04-14 International Business Machines Corporation Organic light emitting diodes having transparent cathode structures
US6306653B1 (en) 1998-01-20 2001-10-23 Codon Diagnostics, Llc Detection and treatment of breast disease
JP2002533403A (en) 1998-12-24 2002-10-08 シェーリング コーポレイション Agonist or antagonist of skin T cell attracting chemokine (CTACK) or vasoactive intestinal constrictor (VIC) chemokine

Also Published As

Publication number Publication date
US20020137107A1 (en) 2002-09-26
WO2002014532A3 (en) 2002-06-13
US6692922B2 (en) 2004-02-17
WO2002014532A2 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU1623200A (en) Method for identifying the language of individual words
AU5382499A (en) Self-evolving database and method of using same
GB0119595D0 (en) Optical tool and method for analysis of formation fluids
AU2002305793A1 (en) Database access bridge system and process
DE69818183D1 (en) SOI MOSFET and method for its production
PL314640A1 (en) Method of vaccinating against coccodiosis
AU9116898A (en) Electronic tag for valve and method of using same
AU1036499A (en) Method and device for the production of pure water
AU5551299A (en) Method of identifying proteins
AU2001286519A1 (en) Method for identifying modulators of "mec"-induced functions of ccr3 and/or ccr10
GB2326952B (en) Method of providing microscopic features
AU2001261676A1 (en) Method and reagent for the inhibition of erg
AU1812601A (en) Cover member and method of making same
GB2391940B (en) Optical tool and method for analysis of formation fluids
AU7383600A (en) A method and system for the simplification of leaf-limited bridges
AU2590199A (en) Aquarium and associated laser device and method of use therefor
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AU2532295A (en) Method of genetic testing
AU3962999A (en) The method of microobjects' study
AUPP421798A0 (en) Process of identification
AU6754800A (en) Integrated system and method of creating intelligent agents
AU8531998A (en) Method and device for producing thin slabs
AU5420099A (en) Method and aid for the early recognition of sunburn
AU6455198A (en) Method for the identification of genetic subtypes
AU8241298A (en) Method for identifying modifiers of the leptin: leptin receptor interaction